Description
Our Gaithersburg, Maryland facility builds life-changing medicines for people around the world. The modern, vibrant scientific campus employs more than 3000 experts in our field, and it is only a short drive from Washington, DC.
It is filled with pioneering technology. Our work areas were built to facilitate collaboration, interaction and cross functional science.
We believe employees benefit from being challenged and inspired at work.
We offer everything from bean bag rooms for creative brain storming, game rooms and Zen garden to treadmill stations and regular campus happy hours.
The Gaithersburg site offer a variety of amenities to help boost productivity and help keep our employees happy and healthy.
This includes a fitness center, employee healthcare clinic, electric vehicle charging stations, dry cleaning and full-service cafeteria.
Overview :
Join us at AstraZeneca as an Executive Director / Global Product Lead (GPL) in Oncology R&D. This role offers the opportunity to lead and be accountable for multiple global cross-functional early global product teams across diverse biological mechanisms.
As the 'CEO' of the asset, you will have the chance to make a big impact and be part of the team that aims to eliminate cancer as a cause of death.
The Executive Director / Global Product Lead (GPL) will have overall leadership and accountability of multiple global cross functional early global product teams across diverse biological mechanisms from candidate selection through Phase III investment decision across 3 of the major platforms (IO, ADC, Cell Therapy).
This individual will be accountable for the strategic leadership and execution for the product candidates (essentially the CEO’ of the asset).
You will have oncology clinical drug development experience, demonstrated leadership, and be able to critically evaluate the science, clinical data and competitive landscape that underlies these programs.
You will be able to effectively communicate across a broad range of audiences and have an ability to clearly articulate project specific strategies as it relates to the overall oncology strategy.
Major Duties and Responsibilities :
- Leads global product teams from preclinical candidate selection through proof of concept leading to Phase III
- Investment decisions. If appropriate, GPLs may have the opportunity to continue to lead assets through late development / registration.
- Single point of accountability for the strategy, budget, timeline and execution of a portfolio of pre-clinical and clinical stage therapeutic candidates.
- Create integrated product development plans which are aligned with business objectives and are differentiated from competitor products.
- Leads and communicates the project development strategy at governance meetings to secure funding and endorsement of the strategy.
- Leads the global project team to effectively manage / mitigate / communicate risk. Responsible for monitoring emerging data and pivot when deemed necessary.
- Responsible for maintaining a high degree of team effectiveness through collaboration, influence, and, as necessary, coaching and mentoring of cross-functional team members.
- Maintains relationships with external investigators to ensure projects are consistent with evolving clinical
Qualifications :
Education : Graduate degree such as a PhD or an MD / PhD is required
Required Experience :
- Demonstrated success in developing oncology agents.
- Industry experience in drug development including experience in early phase non-clinical and / or clinical drug development and regulatory knowledge.
- Strong knowledge and understanding of the Oncology therapeutic area with experience in diverse biological mechanisms.
- Broad understanding of the evolving clinical landscape in oncology.
- Demonstrated experience leading and motivating teams in a highly matrixed environment.
- Proven record of cultivating and managing internal and external cross-functional collaborations.
- Demonstrated success in influencing colleagues and senior leaders in various departments.
- Must demonstrate high integrity.
Desired Skills :
- Experience in the development of biologics is highly desirable.
- ADC and / or IO (T cell engagers, immune redirecting agents, cell therapy, etc) development experience is highly desirable.
- Due diligence experience as GPLs often are required to participate in business development.
Why AstraZeneca?
When we put unexpected teams in the same room, we unleash bold thinking with the power to inspire life-changing medicines.
In-person working gives us the platform we need to connect, work at pace and challenge perceptions. That’s why we work, on average, a minimum of three days per week from the office.
But that doesn't mean we’re not flexible. We balance the expectation of being in the office while respecting individual flexibility.
Join us on our journey of building a new kind of organization to reset expectations of what a bio-pharmaceutical company can be.
This means we’re opening new ways to work, ground-breaking pioneering methods and bringing unexpected teams together. Interested?
Come and join our journey!
So, what’s next?
If you are passionate about the possibilities, don't hesitate in submitting an application today!
Where can I find out more?
Connect with our recruiter - Sam Hunter, or our Talent Scout : Ellen Willcox on LinkedIn, for a confidential discussion or to find out more!
Our Social Media, Follow AstraZeneca on
Follow AstraZeneca on
Follow AstraZeneca on
Next Steps Apply today!
Competitive Remuneration and Flexible benefits apply
Date Posted
18-Apr-2024
Closing Date
Our mission is to build an inclusive and equitable environment. We want people to feel they belong at AstraZeneca and Alexion, starting with our recruitment process.
We welcome and consider applications from all qualified candidates, regardless of characteristics. We offer reasonable adjustments / accommodations to help all candidates to perform at their best.
If you have a need for any adjustments / accommodations, please complete the section in the application form.AstraZeneca requires all US employees to be fully vaccinated for COVID-19 but will consider requests for reasonable accommodations as required by applicable law.